![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 23, 14531-14536, 12, 1984
D Polacek, RE Byrne, M Burrous and AM Scanu
Human high-density lipoprotein class-3 (HDL3) was incubated with freshly
isolated blood polymorphonuclear leukocytes (PMN) at 37 and 4 degrees C. At
both temperatures the release of proteolytic activity (PA) causing the
specific hydrolysis of apo-A-II was dependent on the concentration of HDL3
in the medium. At 37 degrees C, the efflux of PA was linear and no
saturation was reached up to an HDL3 protein concentration in the medium of
800 micrograms/ml. In turn, at 4 degrees C, maximal PA release was reached
at a concentration below 600 micrograms/ml of HDL3 protein/ml in the
medium. Canine HDL, which contains apo-A-I, but not apo-A-II, was as
effective as human HDL3 in promoting the release of PA from PMN. This
property was also exhibited by egg lecithin/cholesterol vesicles containing
apo-A-I. At 4 degrees C, there was no strict correlation between efflux of
PA affected by HDL3 and specific binding of 125I-apo-A-I (HDL3). In
competitive binding experiments, a 50-fold excess of unlabeled HDL3
prevented more than 90% of the binding of 125I-apo-A-I (HDL3) to PMN,
whereas an excess of unlabeled low-density lipoprotein exhibited no effect.
When human HDL3 was incubated with PMN at 4 or 37 degrees C and then
subjected to ultracentrifugation at d 1.21 g/ml, most of the PA that was
initially associated with this lipoprotein was recovered in the bottom of
the tube. By gel filtration, both PA and HDL3 were in the same peak in a
low ionic strength buffer, but were dissociated from each other by a
high-salt solution (d 1.21 g/ml). We conclude that both naturally occurring
HDLs and apo-A-I-stabilized lipid vesicles favor the release from PMN of an
enzymatic activity which cleaves human apo-A- II. This release appears to
be dependent both on the interaction of the cells with the lipoprotein
ligand and on the lipoprotein surface area acting as the acceptor for the
enzyme, probably through electrostatic forces.
Factors controlling the release from human blood polymorphonuclear cells in vitro of a proteolytic activity directed against apolipoprotein A-II
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Edelstein, J. A. Italia, and A. M. Scanu Polymorphonuclear Cells Isolated from Human Peripheral Blood Cleave Lipoprotein(a) and Apolipoprotein(a) at Multiple Interkringle Sites via the Enzyme Elastase. GENERATION OF mini-Lp(a) PARTICLES AND apo(a) FRAGMENTS J. Biol. Chem., April 25, 1997; 272(17): 11079 - 11087. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |